Leber Hereditary Optic Neuropathy Gene Therapy Clinical Trial Recruitment
Authors:
- William J. FeuerWFWilliam J. Feuer
- Fawzi AbukhalilFAFawzi Abukhalil
- Vittorio PorciattiVPVittorio Porciatti
- William W. HauswirthWHWilliam W. Hauswirth
- John GuyJGJohn Guy
Open Access
- 1 September 2010
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 128 (9) , 1129-1135
Abstract
Our understanding of human diseases caused by mutated mitochondrial DNA (mtDNA) has recently evolved dramatically. This is a group of untreatable disorders affecting the eye, nervous system, and heart, some clinically characterized more than a century ago,1 but they are now known to be a spectrum of molecularly defined diseases. In approximately 95% of the cases worldwide, Leber hereditary optic neuropathy (LHON) is caused by 3 pathogenic point mutations in mtDNA coding for the respiratory chain subunits of the nicotinamide adenine dinucleotide ubiquinone-oxidoreductase (complex I) genes: 3460G>A in ND1, 11778G>A in ND4, and 14484T>C in ND6.2 Of these 3 mutations, the 11778G>A resulting in an arginine to histidine substitution at amino acid 340 is responsible for half of the LHON cases. We have chosen to start the journey to gene therapy with one of the most severe, the G11778A mutation in mtDNA responsible for LHON, a disease renowned for causing blindness in later childhood and early adulthood.3 It shows little or no propensity for recovery and there is no effective therapy for this or any disease caused by mutated mtDNA.4Keywords
This publication has 24 references indexed in Scilit:
- Efficiency and Safety of AAV-Mediated Gene Delivery of the Human ND4 Complex I Subunit in the Mouse Visual SystemInvestigative Ophthalmology & Visual Science, 2009
- Physiologic Significance of Steady-state Pattern Electroretinogram Losses in GlaucomaJournal of Glaucoma, 2009
- Mitochondrial Gene Therapy Augments Mitochondrial Physiology in a Parkinson's Disease Cell ModelHuman Gene Therapy, 2009
- Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I TrialHuman Gene Therapy, 2008
- Optimized Allotopic Expression of the Human Mitochondrial ND4 Prevents Blindness in a Rat Model of Mitochondrial DysfunctionThe American Journal of Human Genetics, 2008
- Reversible dysfunction of retinal ganglion cells in non-secreting pituitary tumorsDocumenta Ophthalmologica, 2008
- Reproducibility of Pattern Electroretinogram in Glaucoma Patients with a Range of Severity of Disease with the New Glaucoma ParadigmOphthalmology, 2008
- Safety and Efficacy of Gene Transfer for Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- The Relationship between Retinal Ganglion Cell Function and Retinal Nerve Fiber Thickness in Early GlaucomaInvestigative Ophthalmology & Visual Science, 2006
- Inner retinal contributions to the multifocal electroretinogram: patients with Leber's hereditary optic neuropathy (LHON)Documenta Ophthalmologica, 2004